Skip to main content

NCI Grants to Fund Biomolecular Cancer Detection

NEW YORK (GenomeWeb News) – The National Cancer Institute will fund studies that develop high-throughput methods to discover DNA from tumors and exfoliated cells in human fluids with up to $275,000 over two years.

The goal of the "Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis" grant is to develop new enrichment methods to detect very low levels of materials from tumors such as DNA and cells in body fluids such as sputum.

This research could include development of high-throughput technologies for identifying abnormal exfoliated cells in body fluids; molecular, immunologic, or other technologies to isolate tumor cells or biomolecules to detect tumors; and sampling technologies for capturing and preserving exfoliated tumor cells.

These technologies could be used to measure tumor progression, for early detection, for enrichment and detection of cells and biomolecules, and for using PCR or other methods to detect molecular signatures, said NCI.

Filed under

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.